Shaily Engineering Plastics Ltd
NSE:SHAILY

Watchlist Manager
Shaily Engineering Plastics Ltd Logo
Shaily Engineering Plastics Ltd
NSE:SHAILY
Watchlist
Price: 2 409.1001 INR -0.56% Market Closed
Market Cap: ₹110.7B

Shaily Engineering Plastics Ltd
Investor Relations

Shaily Engineering Plastics Ltd. engages in the manufacture of injection molded plastic components. The company is headquartered in Vadodara, Gujarat. The company went IPO on 2009-10-16. The firm manufactures high precision injection molded plastic components, assemblies, molds and dies for original equipment manufacturer requirements. The company offers a range of technological solutions for patient centric and self-medication injection systems. The company offers drug delivery devices, pen injectors, auto injectors dry powder inhalers (DPI’S) and specialty devices and packaging for pharmaceutical industry. The company manufactures a range of plastic and plastic/electronic children's toys for global markets. The firm also manufactures razors and a range of stylish casing for cosmetics. The company produces components, which are used in the United States defense applications, as well as high-end luxury car turbochargers. Its manufacturing activities are carried out from the plants located in the State of Gujarat, out of which over four plants are in Rania and approximately one plant is in Halol.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Feb 13, 2026
AI Summary
Q3 2026

Strong Growth: Revenue for Q3 FY '26 grew 27% year-on-year to INR 251 crores, with EBITDA up 43% and PAT up 48%.

Healthcare Surge: Healthcare segment revenue more than doubled, and now makes up 42% of total revenue, up from 21% last year.

Capacity Expansion: New pen/auto-injector facility announced in Abu Dhabi, expected to be operational by Q4 FY '28, boosting total pen injector capacity from 80 million to 150 million units per year.

Margin Improvement: EBITDA margin rose to 26.5% (up 310 bps YoY), and PAT margin increased to 14.9% (up 220 bps YoY).

Consumer Weakness: Consumer segment revenue declined 13% YoY due to demand slowdown in Europe and the US.

Future Pipeline: Additional capacity in India is nearly fully booked with contracts; Abu Dhabi facility already has 50-60% capacity committed.

Order-Backed Expansion: Most new capacity is secured through take-or-pay contracts with customers, offering revenue visibility.

Cost Pressures: Q3 saw higher admin and exhibition costs, with some revenue deferred to Q4 due to milestone-based customer confirmations.

Key Financials
Revenue
INR 251 crores
EBITDA
INR 66 crores
EBITDA Margin
26.5%
PAT
INR 37 crores
PAT Margin
14.9%
Consumer Segment Revenue
INR 123 crores
Healthcare Segment Revenue
INR 104 crores
Industrial Segment Revenue
INR 23 crores
Polymer Processed (Q3)
5,541 tonnes
Polymer Processed (9M)
19,209 tonnes
Exports as % Revenue
71%
9M FY '26 Revenue
INR 754 crores
9M FY '26 EBITDA
INR 218 crores
9M FY '26 PAT
INR 130 crores
9M FY '26 EBITDA Margin
29%
9M FY '26 PAT Margin
17.2%
ROCE
38.4%
ROE
29.1%
Debt to Equity
0.3x
Fixed Asset Turnover Ratio
2.0x
Other Earnings Calls

Management

Mr. Mahendra Bhogilal Sanghvi B.Sc.
Executive Chairman
No Bio Available
Mr. Amit Mahendra Sanghvi
MD & Director
No Bio Available
Ms. Tilottama Mahendra Sanghvi B.Sc
Whole Time Director
No Bio Available
Mr. Laxman Bhogilal Sanghvi
Executive Director
No Bio Available
Mr. Paresh Jain
Chief Financial Officer
No Bio Available
Mr. Sanjay Shah
VP & Chief Strategy Officer
No Bio Available

Contacts

Address
GUJARAT
Vadodara
Survey No 366, Rania At & Post Savli
Contacts
+912667244307
www.shaily.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett